FAQ's

According to epidemiological studies and health statistics data, reproductive health challenges affect a significant portion of the global population, prompting many individuals to seek clinical evaluation and professional guidance.

No, infertility is not specific to any single gender. Clinical evaluations show that reproductive health concerns involve female factors in approximately one-third of cases, male factors in another third, and a combination of both or unexplained medical factors in the remaining instances.

Male reproductive health factors most commonly involve:

• Impaired spermatogenesis — producing low sperm count or absence of sperm.
• Sperm parameter issues affecting motility or morphological structure, which influence the ability to reach and fertilize an egg.

Some male factor conditions are congenital, while others develop later in life due to infections, structural changes, or systemic health conditions.

Sperm parameters and overall reproductive health can be influenced by lifestyle factors and medical history. Factors that may impact sperm quality and production include:

• Alcohol consumption
• Substance use
• Environmental toxin or chemical exposures
• Tobacco smoking
• Underlying health conditions
• Certain medications
• Oncological treatments such as radiation or chemotherapy
• Advanced paternal age

Ovulatory dysfunction accounts for a significant portion of female reproductive health concerns. Without regular ovulation, oocytes available for fertilization are limited. Signs of abnormal ovulation often include irregular or absent menstrual cycles. Additional clinical factors associated with female fertility concerns include:

• Fallopian tube blockages or structural damage resulting from pelvic inflammatory disease, endometriosis, or previous surgeries
• Uterine anatomical factors
• Uterine fibroids or polyps

Maternal age is an important clinical factor in reproductive medicine, as ovarian reserve and oocyte quality gradually decline over time, particularly after age 35. Age-related factors impacting female fertility include:

• A natural reduction in the ovarian release of viable oocytes.
• A decline in oocyte quality and chromosomal stability.
• An increased likelihood of systemic health conditions that can influence reproductive outcomes.
• An elevated risk of early pregnancy loss or miscarriage.

Generally, healthy couples under the age of 30 experiencing difficulty conceiving after 12 months of regular, unprotected intercourse are advised to consult a fertility specialist for a comprehensive clinical evaluation. For women aged 35 and older, professional consultation is recommended after 6 months of trying, as reproductive potential requires timely medical assessment.

Infertility management involves medical therapies, surgical interventions, intrauterine insemination (IUI), or assisted reproductive technology (ART), tailored to individual patient evaluations. Treatment recommendations are determined by clinical findings based on:

• Diagnostic test results
• Duration of conception challenges
• Age of both partners
• Overall medical history and health status
• Patient clinical preferences

Male factor treatments may include lifestyle counseling, behavioral support, medical management for hormonal or infectious conditions, or surgical sperm retrieval procedures when indicated.

Female factor treatments frequently involve ovulation-inducing medications, surgical correction of anatomical obstructions, or intrauterine insemination (IUI) following clinical assessment.

Common pharmacological treatments utilized in reproductive medicine include:

• Clomiphene citrate: An oral medication that stimulates ovulation via pituitary signaling, frequently used in managing conditions such as Polycystic Ovary Syndrome (PCOS).
• Human menopausal gonadotropin (hMG) or Gonadotropins: Injectable medications that act directly on the ovaries to stimulate follicular development and ovulation.
• Gonadotropin-releasing hormone (GnRH) analogs: Medications used to regulate the timing of ovulation during treatment cycles.
• Metformin: Used to manage insulin resistance and endocrine imbalances associated with PCOS to support natural ovulatory function.
• Bromocriptine: Prescribed for ovulatory irregularities associated with elevated prolactin levels.

Patients should consult closely with their fertility specialist to understand the specific indications, clinical benefits, and potential side effects of any prescribed fertility medication.

Assisted reproductive technology (ART) encompasses medical procedures used to address fertility challenges. ART procedures typically involve retrieving oocytes from a patient, fertilizing them with sperm in a specialized laboratory environment, and subsequently transferring resulting embryos into the uterine cavity.

Treatment success rates vary significantly based on individual clinical profiles and factors such as:

• Age of the partners
• Underlying medical diagnosis
• Laboratory infrastructure and protocols
• Specific ART modality utilized
• Use of fresh or cryopreserved oocytes and embryos

ART provides clinical options for individuals and couples facing complex reproductive barriers, with protocols designed to prioritize patient safety and clinical management.

Common ART modalities include:

• In Vitro Fertilization (IVF): Fertilization of oocytes and sperm occurs within a laboratory setting. Ovarian stimulation is monitored, oocytes are retrieved, combined with sperm in culture, and resulting embryos are transferred to the uterus.
• Zygote Intrafallopian Transfer (ZIFT): A procedure where fertilization occurs in the laboratory, followed by the surgical transfer of the zygote into the fallopian tube.
• Gamete Intrafallopian Transfer (GIFT): Transfer of unfertilized oocytes and sperm directly into the fallopian tube for in vivo fertilization.
• Intracytoplasmic Sperm Injection (ICSI): An advanced fertilization technique where a single selected spermatozoon is injected directly into a mature oocyte, frequently utilized for severe male-factor conditions.

ART protocols may also incorporate donor gametes (sperm or oocytes) or pre-implantation genetic testing when clinically indicated.

In Vitro Fertilization (IVF) is an assisted reproductive procedure in which oocytes and sperm are united in a specialized laboratory to form embryos. Selected embryos are then transferred to the uterine cavity under ultrasound guidance. This protocol is designed to bypass various anatomical or functional barriers to conception.

IVF is frequently recommended for individuals or couples encountering conditions such as tubal factor infertility, severe male factor parameters, endometriosis, unexplained infertility, or when prior conventional treatments have not yielded results. A formal clinical consultation helps determine appropriate care pathways.

While IVF is established as a structured medical procedure, potential clinical considerations include Ovarian Hyperstimulation Syndrome (OHSS), multiple gestation pregnancies, and procedural events. Clinical teams maintain close patient monitoring protocols throughout treatment to ensure safety and mitigate risks.

A standard IVF treatment cycle typically requires approximately 4 to 6 weeks, encompassing ovarian stimulation, oocyte retrieval, laboratory fertilization, and embryo transfer phases. Additional time may be necessary for preliminary diagnostic evaluations or subsequent protocol cycles.

Yes, IVF integrated with Intracytoplasmic Sperm Injection (ICSI) provides an established approach for addressing male reproductive factors by facilitating fertilization when sperm parameters such as count, motility, or morphology are reduced.

Patients attending their initial consultation are advised to bring relevant past medical records, a complete list of current medications, and a summary of prior diagnostic evaluations. Discussions will focus on medical history, fertility assessments, and individualized care planning.

At our fertility center in Siliguri, complex reproductive health cases are managed through comprehensive diagnostic evaluations and evidence-based treatment planning. Our experienced clinical specialists collaborate closely with patients to deliver structured medical care.

Recognizing the emotional and psychological dimensions of fertility care, our center offers professional counseling and supportive guidance resources to help patients navigate their treatment journey in a compassionate environment.

The number of treatment cycles required varies widely based on individual physiological factors, maternal age, and specific medical diagnoses. Each patient receives personalized clinical guidance regarding expected treatment timelines.

Our fertility center in Siliguri provides a comprehensive spectrum of reproductive services, including IVF, IUI, ICSI, gamete freezing, and advanced diagnostic testing, tailored to meet individual clinical needs.

During an initial consultation, our fertility specialists review medical histories, discuss diagnostic findings, and outline tailored medical management or assisted reproductive options appropriate for the patient profile.

Assisted reproductive treatment at our center involves controlled ovarian stimulation, laboratory fertilization of retrieved oocytes, and embryo transfer under expert clinical supervision. Our team delivers professional care backed by modern laboratory infrastructure.

Choosing New Life Fertility Clinic provides patients access to structured clinical protocols, advanced laboratory facilities, and experienced fertility specialists dedicated to delivering professional, individualized reproductive healthcare.